Blood pressure and cardiorenal responses to antihypertensive therapy in obese women

OBJECTIVE: Blood pressure(BP) and target organ responses to antihypertensive drugs are not well established in hypertensive obese patients. This study is aimed at evaluating the effects of obesity and adiposity distribution patterns on these responses. METHODS: 49 hypertensive obese women were designated to different groups according to waist to hip ratio measurements - 37 with troncular and 12 with peripheral obesity. Patients were treated for 24-weeks on a stepwise regimen with cilazapril alone or a cilazapril/hydrochlorothiazide/amlodipine combination therapy to achieve a BP lower than 140/90mmHg. Ambulatory blood pressure monitoring (ABPM), echocardiography, and albuminuria were assessed before and after the intervention. RESULTS: After 24 weeks, weight loss was less than 2% in both groups. ABPM targets were achieved in 81.5% of patients upon a combination of 2(26.5%) or 3(55.1%) drugs. Similar reductions in daytime-SBP/DBP: -22.5/-14.1(troncular obesity) / -23.6/-14.9mmHg (peripheral obesity) were obtained. Decrease in nocturnal-SBP was greater in troncular obesity patients. Upon BP control, microalbuminuria was markedly decreased, while only slight decrease in left ventricular mass was observed for both groups. CONCLUSIONS: In the absence of weight loss, most patients required combined antihypertensive therapy to control their BP, regardless of their body fat distribution pattern. Optimal target BP and normal albuminuria were achieved in the group as a whole and in both obese patient groups, while benefits to cardiac structure were of a smaller magnitude.

Saved in:
Bibliographic Details
Main Authors: Rosa,Eduardo Cantoni, Zanella,Maria Tereza, Kohlmann,Nárcia Elisa Bellucci, Ferreira,Sandra Roberta Gouveia, Plavnik,Frida Liane, Ribeiro,Artur Beltrame, Kohlmann Jr.,Osvaldo
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Endocrinologia e Metabologia 2008
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27302008000100010
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0004-27302008000100010
record_format ojs
spelling oai:scielo:S0004-273020080001000102008-03-10Blood pressure and cardiorenal responses to antihypertensive therapy in obese womenRosa,Eduardo CantoniZanella,Maria TerezaKohlmann,Nárcia Elisa BellucciFerreira,Sandra Roberta GouveiaPlavnik,Frida LianeRibeiro,Artur BeltrameKohlmann Jr.,Osvaldo Hypertension Obesity Body fat distribution Antihypertensive therapy Echocardiography Albuminuria OBJECTIVE: Blood pressure(BP) and target organ responses to antihypertensive drugs are not well established in hypertensive obese patients. This study is aimed at evaluating the effects of obesity and adiposity distribution patterns on these responses. METHODS: 49 hypertensive obese women were designated to different groups according to waist to hip ratio measurements - 37 with troncular and 12 with peripheral obesity. Patients were treated for 24-weeks on a stepwise regimen with cilazapril alone or a cilazapril/hydrochlorothiazide/amlodipine combination therapy to achieve a BP lower than 140/90mmHg. Ambulatory blood pressure monitoring (ABPM), echocardiography, and albuminuria were assessed before and after the intervention. RESULTS: After 24 weeks, weight loss was less than 2% in both groups. ABPM targets were achieved in 81.5% of patients upon a combination of 2(26.5%) or 3(55.1%) drugs. Similar reductions in daytime-SBP/DBP: -22.5/-14.1(troncular obesity) / -23.6/-14.9mmHg (peripheral obesity) were obtained. Decrease in nocturnal-SBP was greater in troncular obesity patients. Upon BP control, microalbuminuria was markedly decreased, while only slight decrease in left ventricular mass was observed for both groups. CONCLUSIONS: In the absence of weight loss, most patients required combined antihypertensive therapy to control their BP, regardless of their body fat distribution pattern. Optimal target BP and normal albuminuria were achieved in the group as a whole and in both obese patient groups, while benefits to cardiac structure were of a smaller magnitude.info:eu-repo/semantics/openAccessSociedade Brasileira de Endocrinologia e MetabologiaArquivos Brasileiros de Endocrinologia & Metabologia v.52 n.1 20082008-02-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27302008000100010en10.1590/S0004-27302008000100010
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Rosa,Eduardo Cantoni
Zanella,Maria Tereza
Kohlmann,Nárcia Elisa Bellucci
Ferreira,Sandra Roberta Gouveia
Plavnik,Frida Liane
Ribeiro,Artur Beltrame
Kohlmann Jr.,Osvaldo
spellingShingle Rosa,Eduardo Cantoni
Zanella,Maria Tereza
Kohlmann,Nárcia Elisa Bellucci
Ferreira,Sandra Roberta Gouveia
Plavnik,Frida Liane
Ribeiro,Artur Beltrame
Kohlmann Jr.,Osvaldo
Blood pressure and cardiorenal responses to antihypertensive therapy in obese women
author_facet Rosa,Eduardo Cantoni
Zanella,Maria Tereza
Kohlmann,Nárcia Elisa Bellucci
Ferreira,Sandra Roberta Gouveia
Plavnik,Frida Liane
Ribeiro,Artur Beltrame
Kohlmann Jr.,Osvaldo
author_sort Rosa,Eduardo Cantoni
title Blood pressure and cardiorenal responses to antihypertensive therapy in obese women
title_short Blood pressure and cardiorenal responses to antihypertensive therapy in obese women
title_full Blood pressure and cardiorenal responses to antihypertensive therapy in obese women
title_fullStr Blood pressure and cardiorenal responses to antihypertensive therapy in obese women
title_full_unstemmed Blood pressure and cardiorenal responses to antihypertensive therapy in obese women
title_sort blood pressure and cardiorenal responses to antihypertensive therapy in obese women
description OBJECTIVE: Blood pressure(BP) and target organ responses to antihypertensive drugs are not well established in hypertensive obese patients. This study is aimed at evaluating the effects of obesity and adiposity distribution patterns on these responses. METHODS: 49 hypertensive obese women were designated to different groups according to waist to hip ratio measurements - 37 with troncular and 12 with peripheral obesity. Patients were treated for 24-weeks on a stepwise regimen with cilazapril alone or a cilazapril/hydrochlorothiazide/amlodipine combination therapy to achieve a BP lower than 140/90mmHg. Ambulatory blood pressure monitoring (ABPM), echocardiography, and albuminuria were assessed before and after the intervention. RESULTS: After 24 weeks, weight loss was less than 2% in both groups. ABPM targets were achieved in 81.5% of patients upon a combination of 2(26.5%) or 3(55.1%) drugs. Similar reductions in daytime-SBP/DBP: -22.5/-14.1(troncular obesity) / -23.6/-14.9mmHg (peripheral obesity) were obtained. Decrease in nocturnal-SBP was greater in troncular obesity patients. Upon BP control, microalbuminuria was markedly decreased, while only slight decrease in left ventricular mass was observed for both groups. CONCLUSIONS: In the absence of weight loss, most patients required combined antihypertensive therapy to control their BP, regardless of their body fat distribution pattern. Optimal target BP and normal albuminuria were achieved in the group as a whole and in both obese patient groups, while benefits to cardiac structure were of a smaller magnitude.
publisher Sociedade Brasileira de Endocrinologia e Metabologia
publishDate 2008
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27302008000100010
work_keys_str_mv AT rosaeduardocantoni bloodpressureandcardiorenalresponsestoantihypertensivetherapyinobesewomen
AT zanellamariatereza bloodpressureandcardiorenalresponsestoantihypertensivetherapyinobesewomen
AT kohlmannnarciaelisabellucci bloodpressureandcardiorenalresponsestoantihypertensivetherapyinobesewomen
AT ferreirasandrarobertagouveia bloodpressureandcardiorenalresponsestoantihypertensivetherapyinobesewomen
AT plavnikfridaliane bloodpressureandcardiorenalresponsestoantihypertensivetherapyinobesewomen
AT ribeiroarturbeltrame bloodpressureandcardiorenalresponsestoantihypertensivetherapyinobesewomen
AT kohlmannjrosvaldo bloodpressureandcardiorenalresponsestoantihypertensivetherapyinobesewomen
_version_ 1756372643931488256